ReviewJournal of robotic surgery2026
Embodied artificial intelligence in robotic orthopaedic surgery: from intelligent assistance to adaptive surgical autonomy.
Review in Journal of robotic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Body mass index and robotic-assisted total hip arthroplasty: current evidence, technical challenges, and clinical implications-a critical review.Journal of robotic surgery · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite remarkable advances in robotic orthopaedic surgery over the past three decades, current commercial platforms remain precision-assistance technologies rather than truly adaptive intelligent systems. Embodied Artificial Intelligence (Embodied AI) represents a paradigm shift by enabling robots to perceive, reason, learn, and interact continuously with their physical environment through integrated perception-action loops. This structured narrative review examines the emerging role of Embodied AI in orthopaedic robotic surgery, highlights its conceptual differences from existing platforms, and explores its potential to transform surgical planning, intraoperative decision-making, and postoperative care. Six major commercial systems-MAKO (Stryker), ROSA (Zimmer Biomet), CORI/NAVIO (Smith+Nephew), VELYS (DePuy Synthes), ExcelsiusGPS (Globus Medical), and TSolution One (THINK Surgical)-are evaluated with respect to autonomy, adaptive capability, and clinical functionality. Recent advances in multimodal sensor fusion, computer vision, three-dimensional reconstruction, dynamic scene understanding, force and haptic sensing, foundation models, large language models, reinforcement learning, digital twins, and continual learning are synthesised with emphasis on translational relevance across arthroplasty, trauma, spine, and orthopaedic oncology. Critical challenges surrounding safety validation, regulatory governance, cybersecurity, real-time computational performance, ethical considerations, and surgeon-AI collaboration are discussed. Current evidence confirms that commercially available orthopaedic robotic systems are not fully embodied or autonomous, despite documented improvements in surgical accuracy, implant positioning, and workflow efficiency. Safe clinical implementation will require integration of Embodied AI with patient-specific digital twins, graduated autonomy frameworks, adaptive learning architectures, and human-in-command safety systems, supported by robust multicentre validation, standardised performance benchmarks, comprehensive regulatory frameworks, and multidisciplinary collaboration.
Indexed as
Identifiers
42678638What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.